Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Wearable Tremor Therapy Market size was valued at USD 732.54 million in 2024 and is likely to cross USD 2.71 billion by 2037, expanding at more than 10.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of wearable tremor therapy is estimated at USD 798.54 million.
The growth of this market is primarily driven by the increasing prevalence of essential tremor in a large number of populations all across the globe. Around 0.9% population of the world is affected by ET. An illness of the nervous system known as essential tremor is also known as a neurological condition. Shaking of bodily parts that are rhythmic and involuntary is the primary symptom of essential tremor. The most frequently affected body component is the hands, which tremble when performing routine chores like eating, drinking, or fastening shoelaces. Although essential tremor is often not a serious condition, it can get worse over time.
The growth of this wearable tremor therapy market can be attributed to the account of growing awareness of the therapy. An increasing number of awareness campaigns taking place all across the globe by government and private organizations about wearable tremor therapy are raising the demand and as a result, boosting the market expansion of wearable tremor therapy in the projected time period.
Wearable Tremor Therapy Market: Growth Drivers and Challenges
Growth Drivers
- Growing Interest in Non-Pharmacological Approaches - The market for wearable tremor therapy will likely expand as more people become interested in non-pharmacological treatments for illnesses like essential tremors. For treating non-pharmacological invasions for essential tremors, wearable tremor therapy devices provide a collaborative interdisciplinary platform including engineering, biology, robotics, physiotherapy, and clinical testing. Older persons (those over 65) are more likely to have these tremors, with a 4% prevalence.
- Increasing Innovation of New Technologies - The wearable tremor therapy market is also growing as a result of the development of smart gadgets like pressure shoes, smart watches, and smart glasses, among others. These devices have unique capabilities for data collection, processing, storage, and transfer thanks to both sophisticated hardware and software technology. Wearable technology has been widely employed in many industries and has generated a huge amount of demand as a result of the quick advancements in Internet technology and the arrival of machine learning.
- Increasing Consumer Preference – For health issues such as essential tremor treatments like propranolol are utilized. However, these can be proved ineffective and develop drug tolerance. Because more patients poorly respond to this medication, the consumer preference towards wearable tremor therapy rapidly increases. Therefore, this is estimated to accelerate the market expansion of wearable tremor therapy in the projection time period.
- Growing Research and Development Activities – The market players associated with wearable tremor therapy and the governments of various regions are supporting and encouraging research and development activities in the wearable tremor therapy domain. In fact, they are also offering investment for research and development activities across the globe. This is estimated to boost the expansion of the wearable tremor therapy market in the assessment time period.
Challenges
- Limited Reimbursement Offered – Reimbursement for wearable tremor therapy devices can vary depending on the insurance company and the patient’s individual plans. Some insurance companies may not cover these devices at all, or may only cover them for certain conditions. This is predicted to hamper the market expansion of wearable tremor therapy in the upcoming time period.
- Demand for More Clinical Data is Expected to Restrict the Market Expansion in the Future Times
- Limited Battery Live of Devices is Set to Pose Limitation on the Market Growth in the Forecast Period
Wearable Tremor Therapy Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.3% |
|
Base Year Market Size (2024) |
USD 774.09 million |
|
Forecast Year Market Size (2037) |
USD 1.71 billion |
|
Regional Scope |
|
Wearable Tremor Therapy Segmentation
Product Type (Wearable Mechatronic System, Gloves, Orthoses, Handheld External Devices)
Wearable tremor therapy market from the gloves segment is assumed to account for the largest revenue share of 45% by the end of 2037. About 70% of patients with Parkinson's disease have tremors in the early stages of the disease, and more than 25% have tremors during action, most commonly in the hands, making them unable to perform daily activities. New innovations in the field of gloves using a series of motors and sensors, capable of tracking intentional movements and distinguishing them from unintentional movements, are being developed. To maintain the precision of the gloves and contribute to the development of the software that controls them, real data from patients will be used. Gloves designed specifically for each patient are the demand factor driving the growth of this segment.
Distribution Channel (Pharmacies, Online Pharmacies, E-commerce & Online Purchase)
The e-commerce & online purchase segment in the wearable tremor therapy market is estimated to grow substantially during the forecast period. The main factors driving market growth are growing demand from SMEs and other industrial sector areas, as well as macroeconomic growth. Besides, this segment is anticipated to grow on account of easy convenience and a wider range of selection availability with e-commerce and online purchases. In addition, the online purchase is convenient and easy. Patients can purchase wearable tremor therapy devices from the comfort of their own homes without having to go to a store. Online retailers typically have a wider selection of wearable tremor therapy devices than brick-and-mortar stores. This gives patients more options to choose from.
Our in-depth analysis of the global wearable tremor therapy market includes the following segments:
|
Product Type |
|
|
Body Part |
|
|
Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportWearable Tremor Therapy Industry - Regional Synopsis
North America Market Forecasts
North America industry is likely to account for largest revenue share of 33% by 2037. The growth of this market can be primarily driven by increasing incidence of neural disorder in this region. In the United States, the death rate from neural disorder was as high as 47.4 deaths per 100,000 person, reported as per PAHO. Besides this, increasing investment by market players for the innovation of new technologies is also expected boost the market growth of wearable tremor therapy in the anticipated period. The region is being driven by factors like technology advancements, a strong healthcare system, increasing rates of brain cancer and the presence of professionals with expertise in neurosurgery.
Asia Pacific Market Statistics
The wearable tremor therapy market in Asia Pacific is estimated rise significantly during the forecast period. The growth of this market can be primarily attributed on the back of growing healthcare expenditure in the APAC region as a result of increasing urbanization in the region. Besides this, increasing allotment of huge healthcare expenditure hospitals and dispensing medicines for old people is estimated to drive the market growth in the future.
Companies Dominating the Wearable Tremor Therapy Market
- Cala Health, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Klick Health
- Five Microns Inc.
- GYROGEAR Ltd.
- Indeigogo Inc.
- Microsoft Inc.
- Lift Labs
- Neater Solutions
- Steadiwear Inc.
- Readi-Steadi LLC
In the News
- Cala Health launches a device for the treatment of adults with Parkinson's by means of handtremor. The company announced the commercial launch of its nextgeneration Cala kIQ system, an FDA cleared wearable device for relief of hand tremors in people with essential tremor and Parkinson's disease.
- Cala Health, Inc., a company developing wearable therapies for chronic diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Cala Trio™ in October 2020 for the treatment of motor tremor in adults with Parkinson's disease.
Author Credits: Radhika Pawar
- Report ID: 5336
- Published Date: Jan 03, 2025
- Report Format: PDF, PPT
